| D007223 |
Infant |
A child between 1 and 23 months of age. |
Infants |
|
| D007231 |
Infant, Newborn |
An infant during the first 28 days after birth. |
Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants |
|
| D012008 |
Recurrence |
The return of a sign, symptom, or disease after a remission. |
Recrudescence,Relapse,Recrudescences,Recurrences,Relapses |
|
| D002648 |
Child |
A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. |
Children |
|
| D002675 |
Child, Preschool |
A child between the ages of 2 and 5. |
Children, Preschool,Preschool Child,Preschool Children |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000077866 |
Clofarabine |
An adenine arabinonucleoside derivative that acts as an antineoplastic antimetabolite. It is used in the treatment of ACUTE LYMPHOID LEUKEMIA in pediatric patients who have relapsed. |
9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-,2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine,2-Chloro-2'-fluoroarabino-2'-deoxyadenosine,2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine,2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine,Cl-F-ara-A,Clofarex,Clolar,Evoltra,2 Chloro 2' arabino fluoro 2' deoxyadenosine,2 Chloro 2' fluoroarabino 2' deoxyadenosine |
|
| D000227 |
Adenine Nucleotides |
|
Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine |
|
| D000293 |
Adolescent |
A person 13 to 18 years of age. |
Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths |
|
| D001087 |
Arabinonucleosides |
Nucleosides containing arabinose as their sugar moiety. |
Arabinofuranosylnucleosides |
|